{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T11:44:14Z","timestamp":1769082254035,"version":"3.49.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.molmed.2016.05.010","type":"journal-article","created":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T16:46:49Z","timestamp":1465404409000},"page":"713-724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["iPSCs: On the Road to Reprogramming Aging"],"prefix":"10.1016","volume":"22","author":[{"given":"Clara","family":"Soria-Valles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"L\u00f3pez-Ot\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2016.05.010_bib0490","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0495","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrm.2016.8","article-title":"A decade of transcription factor-mediated reprogramming to pluripotency","volume":"17","author":"Takahashi","year":"2016","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2016.05.010_bib0500","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10522-013-9455-2","article-title":"Is aging a barrier to reprogramming? Lessons from induced pluripotent stem cells","volume":"14","author":"Phanthong","year":"2013","journal-title":"Biogerontology"},{"key":"10.1016\/j.molmed.2016.05.010_bib0505","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ceb.2012.10.004","article-title":"Aging and reprogramming: a two-way street","volume":"24","author":"Mahmoudi","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.molmed.2016.05.010_bib0510","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/stem.495","article-title":"Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette","volume":"28","author":"Somers","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.molmed.2016.05.010_bib0515","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Lopez-Otin","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0520","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1101\/gad.173922.111","article-title":"Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state","volume":"25","author":"Lapasset","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2016.05.010_bib0525","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ncb3207","article-title":"NF-\u03baB activation impairs somatic cell reprogramming in ageing","volume":"17","author":"Soria-Valles","year":"2015","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.molmed.2016.05.010_bib0530","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/acel.12182","article-title":"The aging signature: a hallmark of induced pluripotent stem cells?","volume":"13","author":"Rohani","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0535","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2013.12.028","article-title":"Progeria: a paradigm for translational medicine","volume":"156","author":"Gordon","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0540","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nm1786","article-title":"Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging","volume":"14","author":"Varela","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2016.05.010_bib0545","doi-asserted-by":"crossref","first-page":"106ra107","DOI":"10.1126\/scitranslmed.3002847","article-title":"Splicing-directed therapy in a new mouse model of human accelerated aging","volume":"3","author":"Osorio","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2016.05.010_bib0550","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1093\/hmg\/ddt379","article-title":"Back to the future: how human induced pluripotent stem cells will transform regenerative medicine","volume":"22","author":"Svendsen","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2016.05.010_bib0555","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ceb.2012.08.009","article-title":"Reprogramming aging and progeria","volume":"24","author":"Freije","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.molmed.2016.05.010_bib0560","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","article-title":"Human iPSC-based modeling of late-onset disease via progerin-induced aging","volume":"13","author":"Miller","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0565","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1242\/dev.120667","article-title":"When rejuvenation is a problem: challenges of modeling late-onset neurodegenerative disease","volume":"142","author":"Vera","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.molmed.2016.05.010_bib0570","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1474-9726.2011.00743.x","article-title":"Stem cell depletion in Hutchinson\u2013Gilford progeria syndrome","volume":"10","author":"Rosengardten","year":"2011","journal-title":"Aging Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0575","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.stem.2015.09.001","article-title":"Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects","volume":"17","author":"Mertens","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0580","doi-asserted-by":"crossref","first-page":"14647","DOI":"10.1074\/jbc.M112.439893","article-title":"Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses","volume":"288","author":"Fanjul-Fernandez","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2016.05.010_bib0585","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.stemcr.2014.02.006","article-title":"Telomerase protects Werner syndrome lineage-specific stem cells from premature aging","volume":"2","author":"Cheung","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.molmed.2016.05.010_bib0590","doi-asserted-by":"crossref","first-page":"e112900","DOI":"10.1371\/journal.pone.0112900","article-title":"Reprogramming suppresses premature senescence phenotypes of Werner syndrome cells and maintains chromosomal stability over long-term culture","volume":"9","author":"Shimamoto","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2016.05.010_bib0595","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.neuroscience.2006.12.020","article-title":"Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype\u2013phenotype relationship","volume":"145","author":"Kraemer","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.molmed.2016.05.010_bib0600","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrm3822","article-title":"Understanding nucleotide excision repair and its roles in cancer and ageing","volume":"15","author":"Marteijn","year":"2014","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2016.05.010_bib0605","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1093\/hmg\/dds211","article-title":"Evidence for premature aging due to oxidative stress in iPSCs from Cockayne syndrome","volume":"21","author":"Andrade","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2016.05.010_bib0610","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/hmg\/ddw008","article-title":"Cockayne syndrome-derived neurons display reduced synapse density and altered neural network synchrony","volume":"25","author":"Vessoni","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2016.05.010_bib0615","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mrfmmm.2014.08.007","article-title":"DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease","volume":"776","author":"Dupuy","year":"2015","journal-title":"Mutat. Res."},{"key":"10.1016\/j.molmed.2016.05.010_bib0620","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s13238-016-0244-y","article-title":"Modeling xeroderma pigmentosum associated neurological pathologies with patients-derived iPSCs","volume":"7","author":"Fu","year":"2016","journal-title":"Protein Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0625","doi-asserted-by":"crossref","first-page":"523","DOI":"10.5966\/sctm.2012-0024","article-title":"Induced pluripotent stem cells from ataxia-telangiectasia recapitulate the cellular phenotype","volume":"1","author":"Nayler","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.molmed.2016.05.010_bib0630","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1038\/srep05421","article-title":"Ataxia telangiectasia derived iPS cells show preserved x-ray sensitivity and decreased chromosomal instability","volume":"4","author":"Fukawatase","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2016.05.010_bib0635","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/ncomms2824","article-title":"SMRT compounds abrogate cellular phenotypes of ataxia telangiectasia in neural derivatives of patient-specific hiPSCs","volume":"4","author":"Lee","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2016.05.010_bib0640","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1172\/JCI58321","article-title":"Molecular pathogenesis and clinical management of Fanconi anemia","volume":"122","author":"Kee","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2016.05.010_bib0645","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature08129","article-title":"Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells","volume":"460","author":"Raya","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.05.010_bib0650","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1182\/blood-2012-02-408674","article-title":"Overcoming reprogramming resistance of Fanconi anemia cells","volume":"119","author":"Muller","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2016.05.010_bib0655","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/stem.1308","article-title":"Brief report: human pluripotent stem cell models of fanconi anemia deficiency reveal an important role for fanconi anemia proteins in cellular reprogramming and survival of hematopoietic progenitors","volume":"31","author":"Yung","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.molmed.2016.05.010_bib0660","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5966\/sctm.2013-0172","article-title":"Pluripotent cell models of fanconi anemia identify the early pathological defect in human hemoangiogenic progenitors","volume":"4","author":"Suzuki","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.molmed.2016.05.010_bib0665","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nature08792","article-title":"Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients","volume":"464","author":"Agarwal","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.05.010_bib0670","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature10084","article-title":"Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells","volume":"474","author":"Batista","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.05.010_bib0675","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ceb.2014.09.009","article-title":"Lamins: the structure and protein complexes","volume":"32","author":"Gruenbaum","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.molmed.2016.05.010_bib0680","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcdb.2014.03.021","article-title":"Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective","volume":"29","author":"Cau","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.molmed.2016.05.010_bib0685","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson\u2013Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.05.010_bib0690","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1126\/science.1084125","article-title":"Lamin a truncation in Hutchinson\u2013Gilford progeria","volume":"300","author":"De Sandre-Giovannoli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.molmed.2016.05.010_bib0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2012.05.015","article-title":"Unique preservation of neural cells in Hutchinson\u2013Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA","volume":"2","author":"Nissan","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2016.05.010_bib0700","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09879","article-title":"Recapitulation of premature ageing with iPSCs from Hutchinson\u2013Gilford progeria syndrome","volume":"472","author":"Liu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.05.010_bib0705","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2010.12.002","article-title":"A human iPSC model of Hutchinson Gilford progeria reveals vascular smooth muscle and mesenchymal stem cell defects","volume":"8","author":"Zhang","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0710","doi-asserted-by":"crossref","first-page":"380","DOI":"10.18632\/aging.100277","article-title":"Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A\/C","volume":"3","author":"Ho","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.molmed.2016.05.010_bib0715","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18632\/aging.100550","article-title":"An inhibitory role of progerin in the gene induction network of adipocyte differentiation from iPS cells","volume":"5","author":"Xiong","year":"2013","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.molmed.2016.05.010_bib0720","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ajhg.2011.04.010","article-title":"Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome","volume":"88","author":"Puente","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2016.05.010_bib0725","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1002\/ajmg.a.34249","article-title":"Nestor\u2013Guillermo progeria syndrome: a novel premature aging condition with early onset and chronic development caused by BANF1 mutations","volume":"155A","author":"Cabanillas","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.molmed.2016.05.010_bib0730","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/nn.4085","article-title":"Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD\/ALS","volume":"18","author":"Jovicic","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molmed.2016.05.010_bib0735","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nature14974","article-title":"GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport","volume":"525","author":"Freibaum","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.05.010_bib0740","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0745","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.cell.2009.02.013","article-title":"Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors","volume":"136","author":"Soldner","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0750","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.stem.2011.01.013","article-title":"LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress","volume":"8","author":"Nguyen","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0755","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/emmm.201200215","article-title":"Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease","volume":"4","author":"Sanchez-Danes","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.molmed.2016.05.010_bib0760","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2013.10.013","article-title":"LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction","volume":"62","author":"Sanders","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.molmed.2016.05.010_bib0765","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11557","article-title":"Progressive degeneration of human neural stem cells caused by pathogenic LRRK2","volume":"491","author":"Liu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.05.010_bib0770","doi-asserted-by":"crossref","first-page":"e1994","DOI":"10.1038\/cddis.2015.318","article-title":"Elevated alpha-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells","volume":"6","author":"Oliveira","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.molmed.2016.05.010_bib0775","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.1245296","article-title":"Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons","volume":"342","author":"Chung","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.molmed.2016.05.010_bib0780","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1523\/JNEUROSCI.4441-10.2011","article-title":"Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells","volume":"31","author":"Seibler","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2016.05.010_bib0785","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1756-6606-5-35","article-title":"Mitochondrial dysfunction associated with increased oxidative stress and alpha-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue","volume":"5","author":"Imaizumi","year":"2012","journal-title":"Mol. Brain"},{"key":"10.1016\/j.molmed.2016.05.010_bib0790","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/stem.1854","article-title":"Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons","volume":"33","author":"Ren","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.molmed.2016.05.010_bib0795","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ncomms1669","article-title":"Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells","volume":"3","author":"Jiang","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2016.05.010_bib0800","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cell.2011.06.019","article-title":"Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations","volume":"146","author":"Soldner","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0805","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/stem.1415","article-title":"Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons","volume":"31","author":"Sundberg","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.molmed.2016.05.010_bib0810","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.stem.2015.01.018","article-title":"Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease","volume":"16","author":"Hallett","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0815","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature10284","article-title":"Direct generation of functional dopaminergic neurons from mouse and human fibroblasts","volume":"476","author":"Caiazzo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.05.010_bib0820","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1089\/scd.2009.0319","article-title":"Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats","volume":"19","author":"Cai","year":"2010","journal-title":"Stem Cell Dev."},{"key":"10.1016\/j.molmed.2016.05.010_bib0825","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2012.236","article-title":"Deciphering the mechanism underlying late-onset Alzheimer disease","volume":"9","author":"Krstic","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.molmed.2016.05.010_bib0830","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mcn.2015.11.010","article-title":"Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells","volume":"73","author":"Mungenast","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.molmed.2016.05.010_bib0835","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.stem.2015.02.004","article-title":"Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells","volume":"16","author":"Young","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0840","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10821","article-title":"Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells","volume":"482","author":"Israel","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.05.010_bib0845","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.stem.2013.01.009","article-title":"Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular A\u03b2 and differential drug responsiveness","volume":"12","author":"Kondo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0850","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/hmg\/ddu064","article-title":"The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons","volume":"23","author":"Muratore","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2016.05.010_bib0855","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20132451","article-title":"Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease","volume":"211","author":"Lee","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2016.05.010_bib0860","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1089\/scd.2013.0511","article-title":"Induced pluripotent stem cells from familial Alzheimer's disease patients differentiate into mature neurons with amyloidogenic properties","volume":"23","author":"Mahairaki","year":"2014","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.molmed.2016.05.010_bib0865","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1093\/hmg\/ddr394","article-title":"Modeling familial Alzheimer's disease with induced pluripotent stem cells","volume":"20","author":"Yagi","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2016.05.010_bib0870","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1101\/gad.1811609","article-title":"Senescence impairs successful reprogramming to pluripotent stem cells","volume":"23","author":"Banito","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2016.05.010_bib0875","doi-asserted-by":"crossref","first-page":"e14095","DOI":"10.1371\/journal.pone.0014095","article-title":"Mitochondrial rejuvenation after induced pluripotency","volume":"5","author":"Suhr","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2016.05.010_bib0880","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/nature08311","article-title":"Linking the p53 tumour suppressor pathway to somatic cell reprogramming","volume":"460","author":"Kawamura","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.05.010_bib0885","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2008.12.010","article-title":"Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells","volume":"4","author":"Marion","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0890","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nature08235","article-title":"Suppression of induced pluripotent stem cell generation by the p53-p21 pathway","volume":"460","author":"Hong","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.05.010_bib0895","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nature08287","article-title":"A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity","volume":"460","author":"Marion","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.05.010_bib0900","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.stem.2011.10.005","article-title":"The histone demethylases Jhdm1a\/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner","volume":"9","author":"Wang","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0905","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/jcp.25270","article-title":"Valproic acid enhances iPSC induction from human bone marrow-derived cells through the suppression of reprogramming-induced senescence","volume":"231","author":"Chen","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.molmed.2016.05.010_bib0910","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2012.10.016","article-title":"Genome-wide methylation profiles reveal quantitative views of human aging rates","volume":"49","author":"Hannum","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0915","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nature10953","article-title":"Chromatin-modifying enzymes as modulators of reprogramming","volume":"483","author":"Onder","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.05.010_bib0920","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.stemcr.2014.07.003","article-title":"Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells","volume":"3","author":"Frobel","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.molmed.2016.05.010_bib0925","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.aaa1356","article-title":"Aging stem cells. A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging","volume":"348","author":"Zhang","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.molmed.2016.05.010_bib0930","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.stem.2012.10.005","article-title":"Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal","volume":"11","author":"Zhang","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0935","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1474-9726.2011.00722.x","article-title":"Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells","volume":"10","author":"Chen","year":"2011","journal-title":"Aging Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0940","doi-asserted-by":"crossref","first-page":"18439","DOI":"10.1074\/jbc.M112.405928","article-title":"The role of SIRT6 protein in aging and reprogramming of human induced pluripotent stem cells","volume":"288","author":"Sharma","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2016.05.010_bib0945","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/ncb3256","article-title":"Atg5-independent autophagy regulates mitochondrial clearance and is essential for iPSC reprogramming","volume":"17","author":"Ma","year":"2015","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.molmed.2016.05.010_bib0950","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1101\/gad.197954.112","article-title":"Nuclear lamina defects cause ATM-dependent NF-kappaB activation and link accelerated aging to a systemic inflammatory response","volume":"26","author":"Osorio","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2016.05.010_bib0955","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2014.01.005","article-title":"Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation","volume":"156","author":"Ohnishi","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2016.05.010_bib0960","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature12586","article-title":"Reprogramming in vivo produces teratomas and iPS cells with totipotency features","volume":"502","author":"Abad","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2016.05.010_bib0965","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1074\/jbc.M112.391680","article-title":"Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem cell-derived neurons","volume":"288","author":"Rakovic","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2016.05.010_bib0970","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.stemcr.2015.02.019","article-title":"Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines","volume":"4","author":"Shaltouki","year":"2015","journal-title":"Stem Cell Rep."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1471491416300454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1471491416300454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T03:08:22Z","timestamp":1527476902000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491416300454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":97,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1471491416300454"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2016.05.010","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"iPSCs: On the Road to Reprogramming Aging","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.molmed.2016.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}